Activity of the cyclin-dependent kinase (cdk) 1-cyclin B Cip1, which inhibits both wild-type and mutant cdk2-APC/C activation is determined, however, is still not comcyclin E, reverses mitotic arrest under either pletely elucidated. The activity of cdk2 also increases in condition. Our findings indicate that the proteolysismitosis [3, 4]. In cycling Xenopus egg extracts, cdk2 is independent downregulation of cdk2 activity at the primarily found in a complex with cyclin E, and its activity end of mitosis depends on PKA and is required to is required for cdk1 activation at the onset of mitosis [5, activate the proteolysis cascade that leads to 11]. At the end of mitosis, cdk2 activity is downregulated mitosis exit. by inhibitory phosphorylation of cdk2 rather than degradation of cyclin E, which is stable [5, 6, 11, 12]. We used this system to ask whether cdk2 had a role in regulating
Figure 1
The inhibition of cdk2 by p21/Cip1/Waf1 induces premature cyclin degradation. Portions of a cycling Xenopus egg extract, containing [ 1b,c) not only inhibited cdk2 activity but also induced induce cdk1 activation, we added nondegradable ⌬90cyclin B1 [11] . Subsequent activation of the cyclin degradation premature cyclin degradation and MPF inactivation.
pathway was monitored with [
35 S]methionine full-length cyclin B1, which was added along with ⌬90cyclin B1. We then asked if GST-Cip1 prematurely activated cyclin degradation by inhibiting cdk2-cyclin E rather than cdk1- Figure 1d shows that full-length cyclin B1 was stable until 30 min in the control extract and was degraded thereafter cyclin A. Eggs were incubated with cycloheximide (CHX) for 30 min before activation. This treatment yields in-(Cyc B1). The addition of GST-Cip1 after 20 or 15 min of incubation did not inhibit further cdk1 activation, terphase extracts that are depleted of cyclin A and B [11, 13] and therefore lack cdk1 activity that was confirmed which was sustained by nondegradable ⌬90cyclin B1 (Figure 1d ; P-HH1); instead, it induced premature degradaby anti-cyclin A and anti-cyclin B2 immunoprecipitation/ kinase assays (data not shown). The extracts retain cyclin tion of full-length cyclin B1 (Figure 1d ; Cyc B1). These data indicate that cdk2 helps maintain cdk1-cyclin B dur-E, which is stable, and cdk2-cyclin E activity [11, 13]. To Figure 1d . At time 0 of incubation, the following additions were made to extracts samples: (Control) ⌬90cyclin B1 (10 g/ml); (GST-RII) ⌬90cyclin B1 (10 g/ ml) ϩ GST-RII (80 g/ml); (GST-RII ϩ GSTCip1) ⌬90cyclin B1 ϩ GST-RII, then GSTCip1 (100 nM) was added after 40 min; and (GST-RII ϩ cAMP) ⌬90cyclin B1 ϩ GST-RII, then cAMP (600 nM) was added after 40 min. Cyclin degradation was monitored by adding reticulocyte lysate (5% of extract volume), containing [ ing mitosis, blocking the cyclin degradation pathway. We of studying whether cdk2 was in the pathway between PKA and mitotic cyclin degradation. We asked if PKA previously showed that the activity of the cAMP-PKA pathway oscillates during the extracts' cell cycle; it is at promoted degradation of mitotic cyclins and MPF inactivation by downregulating cdk2 activity. We inhibited a minimum at the onset of mitosis and peaks at the transition from mitosis to interphase [14] . The inhibition of PKA with excess recombinant rat PKA regulatory subunit type II␤ in the form of a glutathione-S-transferase fusion PKA arrests the cell cycle in mitosis with high MPF activity and stable cyclins A and B. The reactivation of PKA protein (GST-RII) [15] . We then measured total histone H1 kinase, cdk2, and PKA activities as a function of time restores cyclin degradation and the transition into interphase [15] . Extending the time between activation and of incubation of the extract at 23ЊC. In the control extract (containing GST), total histone H1 kinase and cdk2 activiinactivation of MPF by blocking PKA provided us a means ties oscillated with kinetics similar to those shown in GST-RII-treated extracts by GST-Cip1 or cAMP ( Figure  2e ; GST-RII ϩ GST-Cip1 or cAMP). Taken together, Figure 1 (Figure 2a) . PKA activity rose as cdk2 and total histone H1 kinase activities declined. GST-RII blocked these data indicate that PKA inactivates cdk2, allowing mitosis exit. PKA, stabilized high cdk2 and total histone H1 kinase activities, and prevented the degradation of cyclin B (Figure 2b) . The reactivation of PKA with cAMP induced a To dissect the pathway initiated by PKA, we compared in detail the kinetics of cdk2, PKA, and cyclin B2-and rapid decline in cdk2 and total histone H1 kinase activities and cyclin B concentration (Figure 2c) [15]. To know if cyclin A-associated kinase activities at the end of mitosis. Cdk2 and cyclin A-associated kinase activities peaked and PKA acted through cdk2, we asked if the inactivation of cdk2 could reverse mitotic arrest induced by GST-RII.
declined before cyclin B2-associated activity reached its maximum, consistent with previous results (Figure 3a) [4, Accordingly, GST-Cip1 (100 nM) was added at 50 min of incubation to a portion of a GST-RII-treated extract.
16]. The activity of cdk2 declined slightly prior to cyclin A-associated activity, at approximately the time as PKA Figure 2d shows that GST-Cip1 overcame the effects of PKA inhibition, restoring mitosis exit. These results were activation (Figure 3a) . The four protein kinases were also assayed in a GST-RII-treated extract immediately after confirmed by the morphological examination of sperm nuclei (50/l) added to similar extracts. PKA inhibition PKA reactivation with cAMP ( Figure 3b ). Under these conditions, PKA activity rose more abruptly, while cdk2 fixed sperm chromatin in a condensed state. GST-Cip1-induced chromatin decondensation occurred 10-20 min activity declined significantly more rapidly than cyclin Aor B2-associated activity. The loss of cyclin A-and cyclin after the addition of GST-Cip1 (data not shown). To show that cdk2 activity, rather than cdk1-cyclin A activity, was B2-associated activities paralleled the loss of cyclin A and B2 protein (data not shown). These kinetics show that responsible for mitotic arrest in PKA-inhibited extracts, we prepared cyclin A-depleted extracts from CHX-treated cdk2 inactivation precedes inactivation of cdk1 following PKA activation. Whereas cyclins A and B are degraded at eggs (Figure 2e ). Nondegradable ⌬90cyclin B1 was added to activate cdk1, as described for Figure 1d . Where indithe end of mitosis, the abundance of cyclin E and its association with cdk2 do not vary during the cell cycle cated, PKA was blocked with GST-RII. Full-length cyclin B1, added 40 min after ⌬90cyclin B1, was degraded in [5] . Cdk2 activity appears primarily regulated by changes in cdk2 tyrosine 15 phosphorylation [6, 12]. We immunocontrol extracts (containing GST) but was stable in extracts treated with GST-RII (Figure 2e ; Control and GST-RII).
precipitated cdk2 from samples of a GST-RII-and GST-RII ϩ cAMP-treated extract prepared as in Figure 2b ,c Timely degradation of full-length cyclin B was restored in Cdk2AF-cyclin E delays cyclin degradation and is resistant to PKA. Excess wild-type cdk2-cyclin E delays cyclin degradation but is sensitive to PKA. (a) CSF-arrested extracts were preincubated with [ 35 S]methionine (400 Ci/ml) for 20 min before the addition of CHX (0.2 mg/ml). Then, buffer (control) or wild-type cdk2-cyclin E (Cdk2-Cyc E) or mutant cdk2AF-cyclin E (Cdk2AF-Cyc E) were added at levels equal to the endogenous cdk2 activity, and preincubation was prolonged for 10 min. CaCl 2 (400 M) was then added to all samples at time 0. Purified PKA catalytic subunit (cPKA, 0.08 U/l; Sigma) or GST-Cip1 (300 nM) were immediately added to portions of the cdk2AF-cyclin E-treated samples. Aliquots were taken at the indicated time points after the addition of CaCl 2 , separated on SDS-PAGE, and autoradiographed. The positions of cyclins B are indicated. (b) Extracts were incubated as in (a), but CSF-arrested extracts were treated with 3-to 4-fold higher concentrations of wild-type cdk2-cyclin E (high Cdk2-Cyc E). CaCl 2 (400 M) was added to all samples at time 0. Where indicated, cPKA (0.08 U/l; Sigma) or GSTCip (300 nM) were immediately added to portions of the wild-type cdk2-cyclin E-treated extract. The data shown are representative of four independent experiments. at 70 min incubation (Figure 3c ; lanes 1 and 2, respeccyclin E complex containing such a variant cdk2 (cdk2AF; tively; cell cycle kinetics were also performed as in Figure  thr 14 Ͼ ala, and tyr 15 Ͼ phe) [18] with wild-type cdk2-2b,c). Samples were separated on SDS-PAGE and immucyclin E complex in the exit from M phase after the noblotted with an anti-cyclin E antibody, an anti-cdk2 inactivation of CSF with CaCl 2 . A CSF-arrested extract antibody, and with an antibody that specifically recognizes was preincubated for 20 min with [ 35 S]methionine. Porthe cdk2 phosphotyrosine 15 epitope. The amounts of tions were then mixed with equivalent amounts of wildcyclin E and cdk2 were comparable in the immunoprecipitype cdk2-cyclin E or cdk2AF-cyclin E, equal to the entations from the two samples (Figure 3c ; IP ␣Cdk2), showdogenous level of cdk2 activity. After an additional 10 ing comparable binding of cdk2 to cyclin E (Figure 3c ; Cyc min of preincubation, CaCl 2 was added to all portions to E and Cdk2; lanes 1 and 2). The two samples, however, inactivate CSF and induce cyclin degradation. The rate of differed significantly in their content of cdk2-phosphotycyclin B loss was equivalent in the control and in extracts rosine 15. The GST-RII-treated extract contained little treated with wild-type cdk2-cyclin E-treated (Figure 4a ; phosphorylated, inactive cdk2 (Figure 3c ; P-Y-Cdk2, lane Control and Cdk2-Cyc E). Consistent with our hypothe-1) compared to the same extract after PKA reactivation sis, cdk2AF-cyclin E blocked cyclin B degradation (Figure (Figure 3c ; P-Y-Cdk2, lane 2). We conclude that the 4a; Cdk2AF-Cyc E). The block was resistant to the addicAMP-PKA pathway downregulates cdk2 activity via cdk2 tion of the purified PKA catalytic subunit (cPKA, 0.08 tyrosine 15 phosphorylation. U/l; Figure 4a ; Cdk2AF-Cyc E ϩ cPKA) but was completely overcome by GST-Cip1, which directly inhibits cdk2AF-cyclin E (Figure 4a ; Cdk2AF-Cyc E ϩ GSTOur findings suggest that mitosis exit requires a PKACip1). The addition of wild-type cdk2-cyclin E at a condependent downregulation of cdk2 activity via tyrosine centration 3-to 4-fold higher than the endogenous cdk2 15 phosphorylation. If this is indeed the case, a cdk2 activity also retarded cyclin B degradation (Figure 4b ; variant that cannot be inhibited by phosphorylation high Cdk2-Cyc E). In this case, however, cPKA (0.08 should delay mitosis exit despite active PKA. To assay U/l) restored rapid degradation of cyclin B (Figure 4b ; this, we used extracts derived from nonactivated mature high Cdk2-Cyc E ϩ cPKA), as did GST-Cip1 (Figure 4b ; eggs that are in a stable, cytostatic actor (CSF)-dependent, high Cdk2-Cyc E ϩ GST-Cip1). To confirm the rele-M phase arrest [17] . In these extracts, M phase arrest can vance of the control of cdk2 activity via inhibitory phosbe reversed by the addition of calcium, which inactivates CSF. We compared the effects of a recombinant cdk2-phorylation, we examined the effects of adding an excess of the dual specificity phosphatase Cdc25A that activates
